Youth Substance Use Trends: Highest Rates in History

Aug.24.2022
Youth Substance Use Trends: Highest Rates in History
Marijuana and nicotine e-cigarette usage among young people hit historic highs in 2021, according to a report.

According to a report released by the National Institute on Drug Abuse in the United States, in 2021, the usage rates of cannabis and nicotine electronic cigarettes among young people reached an all-time high level.


Dr. Megan E. Patrick and her colleagues at the University of Michigan's Institute for Social Research in Ann Arbor studied drug use prevalence and trends among young people dating back to 1975 in a monitoring group study. Participants were initially sampled in 12th grade at the age of 18, and then surveyed annually until the age of 30.


Researchers have found that in 2021, the most commonly used substances among young people in the past 12 months were alcohol, marijuana, nicotine e-cigarettes, marijuana e-cigarettes, cigarettes, and other drugs (at 81.8%, 42.6%, 21.8%, 18.7%, and 18.3% respectively). The report showed a binge-drinking rate of 32.0% and a daily marijuana use rate of 10.8%. From 2020 to 2021, there was an increase in monthly marijuana e-cigarette use, a decrease in daily alcohol consumption but an increase in binge drinking, returning to the pre-pandemic levels of 2019. There was also an increase in monthly nicotine e-cigarette use, a decrease in non-medical use of narcotics other than heroin, and a decrease in non-medical use of some stimulants, including amphetamines, Adderall, cocaine, and methamphetamine.


In 2021, there was a high prevalence of cannabis, nicotine e-cigarettes, high-intensity alcohol, and hallucinogens other than LSD within a month, while smoking, excessive drinking, and the use of anesthetics other than heroin, Vicodin, and Oxycodone were at historically low levels.


Dr. Nora Volkow, Director of the National Institute on Drug Abuse, stated in a press release that "understanding how drug use affects young adults' future choices is crucial in helping the next generation avoid harm.


This article contains excerpts or reposts from third-party sources, and their copyright belongs to the original media and authors. If there is any infringement, please contact us for deletion. Any individuals or organizations who wish to repost must contact the author and refrain from reposting directly.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
Jiangsu China Tobacco Industrial Co., Ltd. has disclosed a patent describing a nicotine oral formulation produced using 3D printing technology. The invention enables a three-stage nicotine release system—rapid onset, sustained delivery and long-term release—through a layered structure with varying porosity. The technology reflects growing experimentation within China Tobacco’s research system around precision nicotine delivery for modern oral products.
Mar.09
BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027
BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027
British American Tobacco (BAT) CEO Tadeu Marroco said the group will continue to invest in equipment and technology in Italy and expand capacity for next-generation tobacco products such as e-cigarettes and heated tobacco. BAT’s Trieste innovation hub is slated to receive a total investment of 500 million euros by 2027 and add 16 new production lines.
Feb.03 by 2FIRSTS.ai
JT to Launch New Ploom Stick Variant “EVO Sakura Regular” Nationwide in Japan on April 6
JT to Launch New Ploom Stick Variant “EVO Sakura Regular” Nationwide in Japan on April 6
JT said it will begin rolling out “EVO Sakura Regular,” a new product under the premium EVO brand for the heated tobacco brand Ploom, at convenience stores and tobacco retailers across Japan from April 6. The product has already been on sale since February 3 through the CLUB JT online shop and Ploom Shops nationwide.
Mar.13 by 2FIRSTS.ai
Product | Pixx Nicotine Toothpicks Listed on UK Retail Website, Said to Be Unaffected by Upcoming Vape Tax
Product | Pixx Nicotine Toothpicks Listed on UK Retail Website, Said to Be Unaffected by Upcoming Vape Tax
2Firsts has noted that a nicotine toothpick product named Pixx has appeared on a UK retailer website. The product page describes it as a smoke-free nicotine product, and the packaging image shows “UK MADE.” A nicotine-industry professional wrote on LinkedIn that the UK is set to introduce vape tax changes that may increase pressure on the retail side, and said Pixx is expected not to be included in the upcoming vape tax.
Mar.05 by 2FIRSTS.ai
China Boton Group Posts 2025 Revenue of RMB 1.496 Billion, With E-Cigarette Product Revenue Up 4.6%
China Boton Group Posts 2025 Revenue of RMB 1.496 Billion, With E-Cigarette Product Revenue Up 4.6%
China Boton Group reported its results for the year ended December 31, 2025. Revenue was RMB 1.496 billion, down about 9.5% from RMB 1.653 billion in 2024. Gross profit was RMB 377.1 million, with a gross margin of 25.2%, and the group recorded a net loss of RMB 1.000 billion for the year.
Mar.24 by 2FIRSTS.ai
Special Report|Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain
Special Report|Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain
The U.S. International Trade Commission (ITC) has terminated Investigation 337-TA-1410 after invalidating key vape patent claims asserted by R.J. Reynolds Vapor Company, removing the immediate risk of import bans for dozens of companies. However, a new case—337-TA-1486—has already opened a more consequential legal front, shifting the focus from patent disputes to regulatory compliance across the vape supply chain, including PACT Act reporting, tax compliance, and FDA marketing authorization.
BAT
Mar.11